Skip to content

mebolazine


Previous: MDPV | 🏠 All Substances | 📊 Complete Table | Next: mebutamate


OPSS Properties

Classifications6000
ReasonUnapproved drug, FDA warning letter: synthetic steroid that does not constitute a dietary ingredient
Also Known As
  • 17-beta-hydroxy-2alpha,17-dimethyl-5-alpha-androstan-3-one azine
  • 17β-hydroxy-2α,17-dimethyl-5α-androstan-3-one azine
  • di(methasterone) azine
  • 2α,17α-dimethyl-5α-androstan-17β-ol-3-one azine
  • mebolazina
  • mebolazinum
  • Dostalon
  • 17-beta-hydroxy-2-alpha,17-dimethyl-5-alpha-androstan-3-one azine
  • dymethazine
  • 17-β-hydroxy-2-α,17-dimethyl-5-α-androstan-3-one azine
  • dimetazin
  • mebulazina
  • Roxilon
  • dimethazine
  • DMZ
  • 2alpha,17alpha-dimethyl-5alpha-androstan-17beta-ol-3-one azine
  • 17-β-hydroxy-2α,17-dimethyl-5-α-androstan-3-one azine
  • 17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one azine
Prohibited BecauseUnapproved Drug
FDA Warning Letter
WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents)
Added to DatabaseDecember 30, 2025
Source Last UpdatedJuly 25, 2024
GUID6f5f6523-8760-434c-a645-702ac4f8b01d

References

External Resources

UNII: 69C642I19V · CAS: 3625-07-8

PubChem Properties

Chemical Structure

Interactive 3D Structure

Molecular FormulaC42H68N2O2
Molecular Weight633.0 g/mol
IUPAC Name(2R,3E,5S,8R,9S,10S,13S,14S,17S)-3-[(E)-[(2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13,17-tetramethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-ylidene]hydrazinylidene]-2,10,13,17-tetramethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
InChIKeyPOPWFGNRCCUJGU-RSSVFQIBSA-N

📊 Complete Table | 🏠 All Substances

Substance 535 of 880